US Map / Tennessee
State TN

Clinical Trials in Tennessee

Recruiting clinical trials with at least one study location in Tennessee. Data updated daily from ClinicalTrials.gov.

Total Trials
289
Recruiting Now
289
← Back to US Map
Top Conditions in Tennessee
Advanced Solid Tumor (9)Breast Cancer (8)NSCLC (6)Non Small Cell Lung Cancer (6)Prostate Cancer (5)Advanced Solid Tumors (5)Endometrial Cancer (5)Non-Small Cell Lung Cancer (5)Head and Neck Cancer (4)Ovarian Cancer (4)Colorectal Cancer (4)Hypertension (4)
NCT07173309 N/A
Recruiting
Evaluation of Eye Gaze Sharing in the Operating Room
Condition
Kidney Stones
Enrollment
15 pts
Location
United States
Sponsor
Vanderbilt University Medical
View Trial →
NCT04679844 N/A
Recruiting
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineral...
Condition
Degenerative Disc Disease
Enrollment
60 pts
Location
United States
Sponsor
Kuros Biosurgery AG
View Trial →
NCT07395232 Phase 3
Recruiting
An Efficacy and Safety Study of DFL24498 in the Treatment of AKC
Condition
Atopic Keratoconjunctivitis
Enrollment
138 pts
Location
United States, Italy, Spain
Sponsor
Dompé Farmaceutici S.p.A
View Trial →
NCT06127407 Phase 3
Recruiting
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chon...
Condition
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen
Enrollment
136 pts
Location
United States, Australia, Belgium
Sponsor
Servier Bio-Innovation LLC
View Trial →
NCT05254171 Phase 2, Phase 3
Recruiting
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Ca...
Condition
Pancreatic Cancer Metastatic
Enrollment
600 pts
Location
United States, Australia, Austria
Sponsor
Panbela Therapeutics, Inc.
View Trial →
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06456463 Phase 2
Recruiting
A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults ...
Condition
Acute Myeloid Leukemia
Enrollment
83 pts
Location
United States, Australia
Sponsor
Stemline Therapeutics, Inc.
View Trial →
NCT06388421 N/A
Recruiting
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension As...
Condition
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Enrollment
1,000 pts
Location
United States, Puerto Rico
Sponsor
United Therapeutics
View Trial →
NCT06495710 N/A
Recruiting
Arterial Stiffness and Blood Pressure
Condition
Hypertension
Enrollment
228 pts
Location
United States
Sponsor
VA Office of Research and Deve
View Trial →
NCT06568692 Phase 2
Recruiting
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metast...
Condition
Breast Cancer
Enrollment
90 pts
Location
United States
Sponsor
Processa Pharmaceuticals
View Trial →
NCT05919264 Phase 1, Phase 2
Recruiting
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Condition
Cancer
Enrollment
575 pts
Location
United States
Sponsor
Parabilis Medicines, Inc.
View Trial →
NCT06150664 Phase 1
Recruiting
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Condition
Non Small Cell Lung Cancer
Enrollment
73 pts
Location
United States
Sponsor
Compass Therapeutics
View Trial →
NCT06050252 Phase 2
Recruiting
Durvalumab With Gemcitabine and Cisplatin for the Treatment of High-Risk Resecta...
Condition
Resectable Intrahepatic Cholangiocarcinoma
Enrollment
27 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07462377 Phase 1
Recruiting
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Condition
Epidermal Growth Factor
Enrollment
110 pts
Location
United States
Sponsor
EpiBiologics
View Trial →
Page 12 of 12 — 289 trials total
← Prev